宁夏晓鸣农牧股份有限公司 信息披露暂缓与豁免管理制度 二〇二六年一月 宁夏晓鸣农牧股份有限公司 信息披露暂缓与豁免管理制度 第一章 总则 第一条 为规范宁夏晓鸣农牧股份有限公司（以下简称"公司"）信息披露 暂缓与豁免行为，督促公司及相关信息披露义务人依法合规履行信息披露义务， 保护投资者合法权益，根据《中华人民共和国保守国家秘密法》《中华人民共和 国证券法》《上市公司信息披露管理办法》《上市公司信息披露暂缓与豁免管理 规定（证监会公告〔2025〕8 号）》《深圳证券交易所创业板股票上市规则》《深 圳证券交易所上市公司自律监管指引第 2 号—创业板上市公司规范运作》等法律 法规、规范性文件及《宁夏晓鸣农牧股份有限公司章程》（以下简称"《公司章 程》"）《宁夏晓鸣农牧股份有限公司信息披露管理制度》（以下简称"《信息 披露管理制度》"），结合公司实际情况，制定本制度。 第二条 本制度适用于公司及其他信息披露义务人办理信息披露暂缓、豁免 业务的全部行为，包括暂缓、豁免披露临时报告，以及在定期报告、临时报告中 豁免披露中国证券监督管理委员会（以下简称"中国证监会"）和深圳证券交易 所规定或者要求披露的内容的相关活动。 ...

证券代码：300967 证券简称：晓鸣股份 公告编号：2026-007 宁夏晓鸣农牧股份有限公司 关于计提资产减值准备的公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 宁夏晓鸣农牧股份有限公司（以下简称"公司"）根据《深圳证券交易所创 业板股票上市规则》《企业会计准则第 8 号——资产减值》及公司相关会计政策 的规定，本着谨慎性原则，对合并财务报表范围内的各项需要计提减值的资产进 行了评估和分析，对预计存在可能发生减值损失的相关资产计提减值准备。现将 相关情况公告如下： 一、本次计提减值准备情况概述 （二）本次计提资产减值准备的资产范围和总金额 公司 2025 年 12 月计提各项资产减值准备共计 1,441.12 万元，其中，计提 存货跌价准备 1,438.97 万元，详细如下表：（下表中损失以"-"列示） 单位：元 | 类别 | 项目 | 本期金额 | | --- | --- | --- | | 资产减值损失 | 存货跌价准备 | 14,389,674.53 | | | 合计 | 14,389,674.53 | 二、本次计提资产减值准备的确认标准和计 ...

宁夏晓鸣农牧股份有限公司 年报信息披露重大差错责任追究制度 二〇二六年一月 宁夏晓鸣农牧股份有限公司 年报信息披露重大差错责任追究制度 （四）公司财务、审计部门的工作人员； 第一章 总则 （五）其他对年报信息披露工作负有直接或间接责任的人员。 第四条 年报信息披露重大差错责任追究应当遵循以下原则: 第一条 为提高宁夏晓鸣农牧股份有限公司(以下简称"公司")的规范运作 水平，增强信息披露的真实性、准确性、完整性和及时性，提高公司年度报告(以 下简称"年报")信息披露的质量和透明度，强化信息披露责任意识，根据《中 华人民共和国公司法》《中华人民共和国证券法》《上市公司信息披露管理办法》 《深圳证券交易所创业板股票上市规则》（以下简称"《股票上市规则》"）等 有关法律、法规、规范性文件及《宁夏晓鸣农牧股份有限公司章程》（以下简称 "《公司章程》"）等有关规定，结合公司实际情况，制定本制度。 第二条 本制度所称责任追究，是指由于有关人员不履行或不正确履行职责 或由于其他个人原因发生失职、渎职、失误等行为，造成年报信息披露发生重大 差错或其他不良影响的，公司应当对其进行问责。 本制度所称年报信息披露的重大差错，是指年度 ...

证券代码：300967 证券简称：晓鸣股份 公告编号：2026-006 宁夏晓鸣农牧股份有限公司 关于中债信用为公司发行中期票据提供信用增进服务并由关联方提 供反担保措施的公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 一、关联交易概述 为满足发展需要，宁夏晓鸣农牧股份有限公司（以下简称"公司"）拟向中 国银行间市场交易商协会申请注册发行中期票据，由中债信用增进投资股份有限 公司（下称"中债信用"）为本次发行中期票据提供信用增进服务。如发行注册 完成，公司拟发行第一期中期票据，第一期票据期限为 3 年，金额为人民币 50,000,000.00 元，由公司控股股东、实际控制人魏晓明先生以其持有的公司股 票（股票代码：300967.SZ）股权质押给中债信用作为中债信用为公司提供信用 增进服务的反担保，上述反担保相关协议尚未正式签署，具体条款以中债信用与 关联人经协商达成一致后实际签订的正式协议或合同为准。 根据《深圳证券交易所股票上市规则》（以下简称"《股票上市规则》"） 的相关规定，魏晓明先生为公司关联自然人。因此，其为公司发行中期票据发生 的信用增进服务 ...

证券代码：300967 证券简称：晓鸣股份 公告编号：2026-004 宁夏晓鸣农牧股份有限公司 第五届董事会第二十三次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 宁夏晓鸣农牧股份有限公司（以下简称"公司"）第五届董事会第二十三次 会议于 2026 年 1 月 7 日以电子邮件形式通知全体董事，于 2026 年 1 月 12 日上 午在公司会议室以现场结合通讯表决的方式召开。本次会议应出席董事 9 名，实 际出席董事 9 名（其中董事 PAISAN YOUNGSOMBOON（杨森源）、虞泽鹏 2 人因其 他工作以通讯表决方式出席本次会议）。公司部分高级管理人员列席了会议。会 议由魏晓明董事长主持，本次会议的召集、召开和表决程序均符合《公司法》、 《公司章程》及相关法律法规的规定。 公司第五届董事会审计委员会第十二次会议审议通过本议案，出席会议委员 一致认为，公司拟向中国银行间市场交易商协会申请注册发行总额不超过（含） 人民币 2.00 亿元的中期票据符合公司经营发展的实际需要，有利于优化公司融 资结构，提高资金运用的灵 ...

Core Viewpoint - Xiaoming Co. announced that in December 2025, the company sold 22.5252 million chickens, generating sales revenue of 66.0337 million yuan, with a quarter-on-quarter increase of 18.30% in sales volume and 41.51% in revenue, while year-on-year figures showed a decline of 20.37% in sales volume and 37.07% in revenue [2] Group 1 - The company sold 22.5252 million chickens in December 2025 [2] - The sales revenue reached 66.0337 million yuan [2] - Quarter-on-quarter growth was 18.30% in sales volume and 41.51% in revenue [2] Group 2 - Year-on-year decline was 20.37% in sales volume and 37.07% in revenue [2]

Group 1 - China Shipbuilding Defense expects a net profit of 940 million to 1.12 billion yuan for 2025, an increase of 149.61% to 196.88% year-on-year [1] - China First Heavy Industries has only undertaken a small number of related accessory projects and has not generated revenue from them [2] - Huanyu Electronics plans to invest 30 million yuan in a private equity fund focused on AI and emerging industries [3] Group 2 - Zhixiang Jintai's GR1803 injection has been included in the priority review list by the National Medical Products Administration [4] - JianKai Technology's shareholder plans to reduce holdings by up to 3% of the company's shares [5] - Debon Holdings will continue to suspend trading from January 12 due to significant matters being planned [6] Group 3 - South Network Technology's shareholder intends to transfer 847.05 million shares, accounting for 1.50% of the total share capital [7] - Hengrui Medicine has received approval for clinical trials of four drugs [8] - Daotong Technology expects a net profit of 900 million to 930 million yuan for 2025, a year-on-year increase of 40.42% to 45.10% [10] Group 4 - Betta Pharmaceuticals has invested 50 million yuan to acquire a 20% stake in Hangzhou Zhixing Pharmaceutical [11] - Tianyu Biology reported a 10.38% year-on-year decline in cumulative sales revenue for 2025 [12] - Lifang Pharmaceutical's subsidiary has obtained a drug registration certificate for a pain relief product [13] Group 5 - R&F Properties reported a total sales revenue of approximately 14.21 billion yuan for 2025 [14] - Wanfu Biology expects a net profit decline of 87.71% to 91.81% for 2025 [15] - Dazhi expects a negative net profit for 2025 [16] Group 6 - Dongzhu Ecology is negotiating to terminate the acquisition of control over a satellite communication company [17] - Baotai has received a milestone payment of 10 million USD from Hikma Pharmaceuticals [18] - Huace Navigation expects a net profit of 670 million to 690 million yuan for 2025, a year-on-year increase of 14.84% to 18.27% [19] Group 7 - Shenzhen Gas reported a net profit decline of 3.45% for 2025 [20] - Baogang Co. plans to adjust the price of rare earth concentrate for Q1 2026 to 26,834 yuan per ton [21] - Jiuding Investment expects to report a loss for 2025 [22] Group 8 - Shanghai Pharmaceuticals has received a drug registration certificate for a treatment for myasthenia gravis [23] - Hualan Biological plans to acquire a 35% stake in Guangfeng Capsule [24] - Ruina Intelligent plans to invest 169.9 million yuan in a new R&D production base for heat pumps [25] Group 9 - Wantong Development expects to report a loss for 2025 [26] - Xianghe Industrial has completed the purchase of a 5% stake in Hezhixiang Technology [27] - Guangkang Biochemical received a warning letter from the Guangdong Securities Regulatory Commission [28] Group 10 - Xiaoming Co. reported a 37.07% year-on-year decline in chicken product sales revenue for December 2025 [29] - Luokai Co. won a procurement project from State Grid Fujian Power worth approximately 48.2 million yuan [30] - Minhe Co. reported a 65.22% year-on-year increase in the sales of commodity chick seedlings for December 2025 [31] Group 11 - Zhenghai Biological has obtained a registration certificate for calcium silicate bio-ceramic materials [32] - Three Gorges Energy reported a 5.99% year-on-year increase in cumulative total power generation for 2025 [33] - Huisheng Biological expects a net profit of 235 million to 271 million yuan for 2025 [34] Group 12 - Maihe Co. announced the release of the detention measures against its chairman [35] - Wandong's Alzheimer's project has been included in a national major special project for innovative drug development [36] - Kangxin New Materials plans to transfer forest land assets with a book value of 1.203 billion yuan [37] Group 13 - Greenland Holdings expects a net loss of 16 billion to 19 billion yuan for 2025 [39] - Zhongxin Fluorine Materials has obtained a pesticide production license [40]

Core Viewpoint - The company reported significant month-on-month increases in chicken product sales volume and revenue, but year-on-year figures show a decline due to industry challenges such as supply-demand imbalance and low prices [1] Group 1: Sales Performance - In December 2025, the company sold 22.5252 million chickens, generating revenue of 66.0337 million yuan, with month-on-month changes of 18.30% and 41.51% respectively [1] - The average selling price for the month was 2.93 yuan per chicken [1] Group 2: Industry Challenges - Year-on-year sales volume and revenue decreased by 20.37% and 37.07% respectively, indicating significant pressure from the industry [1] - High inventory levels of laying hens have led to notable supply pressure, while market consumption remains weak [1] - Continuous losses in chicken farming and weak pig prices are further suppressing the demand for chicken products [1]

Core Viewpoint - Xiaoming Co., Ltd. (300967.SZ) announced its sales forecast for chicken products in December 2025, projecting sales of 22.5252 million birds and revenue of 66.0337 million yuan, indicating significant changes in sales performance compared to previous periods [1] Group 1: Sales Performance - The company expects to sell 22.5252 million chickens in December 2025, which represents a quarter-on-quarter increase of 18.30% [1] - The projected sales revenue of 66.0337 million yuan shows a quarter-on-quarter increase of 41.51% [1] - Year-on-year comparisons reveal a decrease in sales volume by 20.37% and a revenue decline of 37.07% [1]

Core Viewpoint - The company reported significant month-on-month growth in chicken product sales and revenue for December 2025, but year-on-year comparisons reveal ongoing challenges in the industry due to supply-demand imbalances and low prices [1]. Company Summary - In December 2025, the company sold 22.5252 million chickens, generating sales revenue of 66.0337 million yuan [1]. - Month-on-month changes for sales volume and revenue were 18.30% and 41.51%, respectively [1]. - Year-on-year changes showed a decline in sales volume and revenue of -20.37% and -37.07%, respectively [1]. Industry Summary - The industry continues to face dual pressures from a phase of supply-demand imbalance and persistently low prices [1].